FRABOC Explained: What It Means for Breast and Ovarian Cancer Risk

Learning that breast or ovarian cancer has affected someone in your family can naturally raise questions. You may wonder whether your own risk is higher, whether you need different screening, or whether a cancer-related gene could be involved. This is where FRABOC comes into the conversation.

FRABOC stands for Familial Risk Assessment – Breast and Ovarian Cancer. It was an Australian clinical risk-assessment tool designed to help health professionals look at a person’s family history and identify patterns that could suggest an increased inherited cancer risk.

FRABOC was not a test for cancer, and it could not tell someone with certainty whether they would develop cancer. Instead, it helped turn family-history information into a more structured assessment.

The original FRABOC tool is no longer the current approach. Australian breast cancer risk assessment has developed, with tools such as iPrevent now providing a broader assessment that combines family history with other personal risk factors. Understanding FRABOC, however, remains useful because it explains an important principle that still applies today: family history should be interpreted carefully rather than simply counted.

What Is FRABOC?

FRABOC, or Familial Risk Assessment – Breast and Ovarian Cancer, was designed around the idea that patterns of cancer within a family can sometimes provide clues about inherited risk.

The assessment focused particularly on breast and ovarian cancer and helped healthcare professionals consider information such as which relatives had cancer, what type of cancer they had, and how old they were when diagnosed.

This matters because having cancer somewhere in a family is common. Cancer Council Australia explains that cancer can occur within families by chance, through shared environmental or lifestyle factors, or because of an inherited gene change. Only a small proportion of cancers are attributable to inherited faulty genes.

Therefore, FRABOC was about identifying meaningful patterns, not assuming that every family cancer diagnosis represented hereditary cancer.

What Does FRABOC Stand For?

The name itself describes the purpose of the assessment. “Familial” refers to family relationships, while “risk assessment” means estimating whether the available information suggests an increased chance of developing cancer. The final part of the name refers specifically to breast and ovarian cancer.

The connection between these cancers is important because certain inherited gene changes can increase the risk of both. BRCA1 and BRCA2 are particularly well-known examples. Cancer Council Australia notes that these genes are important in hereditary breast and ovarian cancer.

FRABOC therefore belongs to a wider area of medicine concerned with familial breast and ovarian cancer, hereditary cancer risk, genetic counselling, and appropriate screening.

How Did the FRABOC Assessment Work?

The basic idea was straightforward: build a detailed family cancer history and interpret it in a clinical context.

A healthcare professional could ask about parents, siblings, grandparents, aunts, uncles and other blood relatives. The type of cancer mattered, as did the age at which it was diagnosed. A pattern involving several relatives could be more significant than one isolated diagnosis.

The assessment could help determine whether a person appeared to have average or increased familial risk and whether additional assessment might be appropriate.

Importantly, this process did not diagnose cancer. It also did not prove that a person carried a particular genetic mutation. Instead, it helped identify people whose family history might justify closer investigation.

Is FRABOC Still Available in Australia?

The original FRABOC tool is no longer the current risk-assessment tool. Australian practice has moved toward broader, more detailed approaches to breast cancer risk assessment.

One important current tool is iPrevent, developed by Peter MacCallum Cancer Centre. Its assessment considers family history alongside reproductive, lifestyle, medical and previous breast-disease information. It can calculate estimated breast cancer risk over the next 10 years and across the remaining lifetime.

This change reflects an important development in medicine. Breast cancer risk is not determined by one factor. A person’s overall risk can involve genetics, family history, age, breast density, reproductive factors, previous breast conditions and lifestyle-related factors.

Why Does Family History Matter?

Family history remains an important part of breast cancer risk assessment.

Cancer Council Australia reports that women with a first-degree relative, such as a parent, sibling or child, who has had breast cancer have approximately twice the risk of developing breast cancer compared with women without such a family history. The increase can be greater when the first-degree relative was diagnosed at a younger age.

At the same time, most people who develop breast cancer do not have a strong family history. This is an important balance to understand. A relative’s diagnosis should not automatically be interpreted as evidence of a hereditary cancer syndrome.

What matters is the complete picture.

Which Family History Details Matter?

The number of affected blood relatives can be important. So can their ages at diagnosis and the types of cancer they developed.

A family containing several relatives with breast or ovarian cancer may deserve closer attention, particularly when the cancers occurred at relatively young ages. Male breast cancer can also be an important clue. Certain combinations of breast, ovarian, pancreatic and prostate cancers can also contribute to the assessment of hereditary cancer risk.

Cancer Council Australia recommends considering both the number of affected relatives and the pattern and age of cancer diagnoses when evaluating whether an inherited faulty gene could be involved.

Known BRCA1 or BRCA2 variants are especially important, but they are not the only genes that can be associated with hereditary breast cancer.

Why Your Father’s Side Matters Too

Your family cancer history is not limited to your mother’s side.

Inherited gene changes can come from either parent. This means a person’s father’s family can provide important information about hereditary breast and ovarian cancer risk even when the father himself has never developed cancer.

For this reason, a useful family history should include both maternal and paternal relatives. Cancer Council Australia specifically recommends looking at cancer patterns on both sides of the family.

This can sometimes be difficult when relatives are distant, family relationships are complicated, or medical records are unavailable. Even approximate information can be useful when beginning a discussion with a GP or genetic service.

The Three FRABOC Risk Categories

The FRABOC framework described broad categories of familial risk rather than providing a diagnosis.

The first was at or slightly above average risk. This included the large majority of women whose family history did not indicate a strong inherited cancer pattern. Being in this category did not mean having zero risk; it meant that the available family-history information did not suggest a substantially elevated familial risk.

The second was moderately increased risk. This reflected a more notable family history where the pattern suggested increased risk but did not necessarily indicate a high-risk inherited syndrome.

The third was potentially high risk. A stronger family pattern could lead to referral to a Family Cancer Clinic for more detailed assessment, genetic counselling and possible genetic testing.

Current Australian risk terminology also uses average, moderate and high-risk categories. iPrevent, for example, defines average risk as less than 1.5 times population risk, moderate risk as 1.5 to 3 times population risk, and high risk as more than three times population risk.

What Does Higher Risk Actually Mean?

The word “risk” can sound frightening, but it has a specific medical meaning.

Higher risk does not mean that a person has cancer. It also does not mean that cancer is certain to develop. It means the estimated chance is higher than that of a relevant comparison population.

This distinction is particularly important when discussing inherited genes. Cancer Council Australia explains that even people who inherit a faulty gene that increases cancer risk do not necessarily develop the disease.

A risk assessment is therefore useful because it can help determine whether additional monitoring, genetic assessment, prevention strategies or other medical discussions may be appropriate.

What Is iPrevent?

iPrevent is a current Australian breast cancer risk-assessment and risk-management tool developed by Peter MacCallum Cancer Centre.

It collects information about family history and personal factors. Its family-history questions can include breast, ovarian, pancreatic and prostate cancers and the approximate ages at diagnosis. It also considers reproductive and lifestyle factors and previous breast disease.

The tool uses validated mathematical risk models, including IBIS and BOADICEA through CanRisk, depending on the information entered. It presents estimated breast cancer risk over the next 10 years and across the remaining lifetime and provides information about relevant screening and prevention options.

The current iPrevent information says the tool was last reviewed for accuracy in 2024.

FRABOC vs iPrevent

FRABOC and iPrevent should not be treated as identical tools.

FRABOC was focused strongly on familial breast and ovarian cancer risk and helped organize family-history information into broad risk categories. iPrevent takes a broader approach to breast cancer risk by combining family history with personal and other established risk factors.

This includes reproductive factors, lifestyle factors, previous breast disease and family history involving several relevant cancers.

The change illustrates how cancer-risk assessment has evolved. Rather than asking only whether cancer runs in the family, modern assessment can consider how several risk factors interact to produce an individual’s overall estimated risk.

Quick Bio Information

When Might Genetic Testing Be Considered?

Genetic testing is different from a familial risk assessment.

Genetic testing examines a person’s genes to look for particular inherited variants. In Australia, testing is generally considered when someone has a sufficiently strong indication based on their personal cancer history, family history or other clinical factors. Cancer Council Australia notes that genetic testing is appropriate for a relatively small number of people referred to family cancer clinics.

BRCA1 and BRCA2 are well-known examples, although other genes can also be relevant. Current Australian clinical guidance identifies a range of genes associated with breast and ovarian cancer predisposition.

Genetic counselling can help explain what testing could mean before a person decides whether testing is appropriate.

What Happens If Your Family History Suggests Higher Risk?

A higher-risk family history does not mean that a person is left to manage the situation alone.

A GP may begin by reviewing the family history and deciding whether specialist referral is appropriate. Family Cancer Clinics can provide information about inherited cancer, individual risk, screening and risk-reduction strategies and may provide genetic testing when appropriate.

For people whose risk is substantially increased, Australian guidance may consider more intensive surveillance or prevention strategies. Depending on the circumstances, options can include risk-reducing medication or, for some very high-risk women, risk-reducing surgery. These decisions require individualized medical advice rather than a one-size-fits-all approach.

How Can You Prepare for a Risk Assessment?

Before speaking with a GP, it can be helpful to gather as much family information as reasonably possible.

Try to establish which blood relatives had cancer, what type of cancer they had, and approximately how old they were when diagnosed. Information about breast, ovarian, pancreatic and prostate cancers can be particularly relevant to hereditary breast cancer assessment.

You do not need a perfect family tree before asking for help. iPrevent’s current patient information notes that approximate ages can be entered when exact details are unavailable, although more complete information can make the assessment more useful.

Final Thoughts

FRABOC is important to understand because it represents an earlier Australian approach to answering a difficult but common question: Does my family’s cancer history change my own risk?

The most useful lesson is not simply the name of the old tool. It is the principle behind it. Family history needs context. One cancer diagnosis in a family does not automatically indicate an inherited cancer syndrome, while a pattern involving several relatives, younger diagnoses or particular combinations of cancers can deserve closer attention.

Modern tools such as iPrevent take this idea further by combining family history with a wider range of personal risk factors and providing individualized breast cancer risk estimates.

If breast or ovarian cancer has occurred in your family, the most practical step is to document what you know and discuss it with your GP. A proper assessment can help separate ordinary uncertainty from information that genuinely deserves further investigation. It can also help ensure that screening, genetic counselling or other options are considered according to your individual circumstances and current Australian guidance.

FRABOC may be an older term, but the question it addressed remains highly relevant: understanding family history can be an important part of understanding personal cancer risk.

Common Questions About FRABOC

Is FRABOC A Cancer Test?

No. FRABOC was a risk-assessment tool, not a test used to diagnose breast or ovarian cancer. It was intended to help healthcare professionals interpret family-history patterns and determine whether further assessment might be appropriate.

Is FRABOC Still Available?

The original FRABOC tool is no longer the current approach. Modern Australian breast cancer risk assessment can use tools such as iPrevent, which considers a broader range of personal and family risk factors.

Does Having A Mother With Breast Cancer Mean I Am High Risk?

Not necessarily. A first-degree relative with breast cancer is an important risk factor, but the overall assessment also considers factors such as the relative’s age at diagnosis, other affected relatives, genetic information and personal risk factors.

Does My Father’s Family History Count?

Yes. Inherited cancer-related gene changes can come from either parent. Looking only at your mother’s family can therefore miss important information. Cancer Council Australia recommends considering cancer history on both sides of the family.

Can FRABOC Detect A BRCA Mutation?

No. FRABOC did not directly detect genetic mutations. Genetic testing is a separate process that can examine genes such as BRCA1 and BRCA2 when testing is clinically appropriate.

Does Ovarian Cancer In My Family Matter?

Yes. Ovarian cancer can be an important part of a hereditary breast and ovarian cancer assessment. Family patterns involving breast and ovarian cancer may prompt consideration of specialist genetic assessment.

What Should I Do If Several Relatives Have Had Breast Cancer?

Speak with your GP and provide as much information as possible about the relatives, their diagnoses and their ages at diagnosis. A strong family pattern may justify referral to a Family Cancer Clinic for more detailed risk assessment and possible genetic counselling or testing.

Learn more and explore exciting content on: MMSBRE Explained: What It Is, What It Means, and Why It Matters